As the United States' opioid epidemic rages on, health officials are busy looking for ways to help with the response. Now, right on the heels of the FDA's approval for a new overdose rescue medication ...

Many factors contribute to this heightened risk, underscoring the urgent need for comprehensive, wraparound services and ...

How do you convince wealthy people to invest in whisky they might never get to drink? By creating a whisky tasting room in Midtown that feels like a speakeasy. That’s the goal of Braeburn Whisky, a ...

Dec 30 (Reuters) - Braeburn Pharmaceuticals Inc filed with U.S. regulators on Friday to raise up to $150 million in an initial public offering, seven months after its implant to treat opioid addiction ...

At least that’s what company founder and owner, Glenn Moore, had to say when describing the products he had on display at this year’s AHR Expo in Atlanta. As a small- to medium-sized company, it’s ...

Braeburn Pharmaceuticals has filed for a $150 million IPO. The listing is intended to give Braeburn the financial clout to commercialize its six-month opioid addiction implant that won FDA approval ...